CHONDRIAL THERAPEUTICS

chondrial-therapeutics-logo

Chondrial Therapeutics s a clinical-stage biotechnology company focused on the treatment of rare diseases. It is dedicated to the pursuit of scientific research leading to the treatment for Friedreichโ€™s Ataxia and other mitochondrial diseases.

#SimilarOrganizations #People #Financial #More

CHONDRIAL THERAPEUTICS

Industry:
Biotechnology Health Care Therapeutics

Founded:
2013-01-01

Address:
Bala Cynwyd, Pennsylvania, United States

Country:
United States

Total Employee:
1+

Status:
Active

Contact:
317-370-2234

Email Addresses:
[email protected]

Total Funding:
49.4 M USD

Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail Microsoft Azure DNS Amazon Virginia Region Amazon Route 53 Mimecast Ninja Forms


Similar Organizations

aimmune-therapeutics-logo

Aimmune Therapeutics

Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.

cedilla-therapeutics-logo

Cedilla Therapeutics

Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.

fulcrum-therapeutics-logo

Fulcrum Therapeutics

Fulcrum Therapeutics is a biotechnology company that develops new medicines to treat patients with rare genetic diseases.

harpoon-therapeutics-logo

Harpoon Therapeutics

Harpoon Therapeutics is a clinical-stage immunotherapy company developing novel T cell engagers (TriTACs) for the treatment of cancer.

juventas-therapeutics-logo

Juventas Therapeutics

Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.

nivalis-therapeutics-logo

Nivalis Therapeutics

Nivalis Therapeutics is a clinical-stage pharmaceutical company developing a novel class of disease modifying therapies.

larimar-therapeutics-logo

Larimar Therapeutics

Larimar Therapeutics is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases.

Current Employees Featured

carole-ben-maimon_image

Carole Ben Maimon
Carole Ben Maimon Chief Executive Officer @ Chondrial Therapeutics
Chief Executive Officer
2016-12-01

r-mark-payne_image

R. Mark Payne
R. Mark Payne CSO & Co-founder @ Chondrial Therapeutics
CSO & Co-founder

john-berman_image

John Berman
John Berman Vice President of Finance And Operations @ Chondrial Therapeutics
Vice President of Finance And Operations
2017-01-01

not_available_image

Jennifer Johansson
Jennifer Johansson Vice President of Regulatory Affairs and Counsel @ Chondrial Therapeutics
Vice President of Regulatory Affairs and Counsel

Founder


r-mark-payne_image

R. Mark Payne

Investors List

deerfield-management_image

Deerfield Capital Management

Deerfield Capital Management investment in Series A - Chondrial Therapeutics

deerfield_image

Deerfield

Deerfield investment in Series A - Chondrial Therapeutics

More informations about "Chondrial Therapeutics" on Search Engine